BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7681990)

  • 1. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
    Richter W; Shi Y; Baekkeskov S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes.
    Augstein P; Schlosser M; Ziegler B; Hahmann J; Mauch L; Ziegler M
    Acta Histochem; 1996 Apr; 98(2):229-41. PubMed ID: 8739307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase.
    Schwartz HL; Chandonia JM; Kash SF; Kanaani J; Tunnell E; Domingo A; Cohen FE; Banga JP; Madec AM; Richter W; Baekkeskov S
    J Mol Biol; 1999 Apr; 287(5):983-99. PubMed ID: 10222205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
    Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
    Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of an autoreactive epitope within glutamate decarboxylase using a diabetes-associated human monoclonal autoantibody and an epitope cDNA library.
    Richter W; Northemann W; Müller M; Böhm BO
    Hybridoma; 1996 Apr; 15(2):103-8. PubMed ID: 8743289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
    Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
    J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase-67 (GAD67): expression relative to GAD65 in human islets and mapping of autoantibody epitopes.
    Cram DS; Faulkner-Jones B; Kun J; Harrison LC
    Endocrinology; 1995 Mar; 136(3):1111-9. PubMed ID: 7532577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.
    Richter W; Eiermann TH; Endl J; Seissler J; Wolfahrt S; Brandt M; Jungfer H; Scherbaum WA
    Diabetologia; 1993 Aug; 36(8):785-90. PubMed ID: 7691667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered variants of human glutamic acid decarboxylase (GAD) and autoantibody epitope recognition.
    Primo ME; Anton EA; Villanueva AL; Poskus E; Ermácora MR
    Clin Immunol; 2003 Jul; 108(1):38-45. PubMed ID: 12865069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity.
    Fenalti G; Hampe CS; Arafat Y; Law RH; Banga JP; Mackay IR; Whisstock JC; Buckle AM; Rowley MJ
    Diabetes; 2008 May; 57(5):1293-301. PubMed ID: 18184926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
    Park H; Yu L; Kim T; Cho B; Kang J; Park Y
    Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
    Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
    Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
    Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.